e coli k 12 mg1655 (ATCC)
95
Structured Review
ATCC
e coli k 12 mg1655
E Coli K 12 Mg1655, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 664 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e+coli+k+12+mg1655/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc13093741-303-19-23
Average 95 stars, based on 664 article reviews
E Coli K 12 Mg1655, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 664 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e+coli+k+12+mg1655/Escherichia+coli+(Migula)+Castellani+and+Chalmers/pmc13093741-303-19-23
Average 95 stars, based on 664 article reviews
e coli k 12 mg1655 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Produced:Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. The NF is produced by fermentation with a genetically modified strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. Given that the NF would be consumed to the same extent as the already authorised 3′‐SL sodium salt and taking into account the intrinsic nature of HiMOs with their limited absorption, the absence of toxicologically relevant effects and considering that breastfed infants are naturally exposed to this substance, the Panel considers that the consumption of 3′‐SL in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐3SL_01) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. On the basis of the spectroscopic and chromatographic evidence, the Panel considers that the 3′‐SL present in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐3SL_01) of Article Title: Safety of 6′‐sialyllactose (6′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐6SL_02) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. Given that the NF would be consumed to the same extent as the already authorised 6′‐SL sodium salt and taking into account the intrinsic nature of HMOs with their limited absorption, the absence of toxicologically relevant effects and considering that breastfed infants are naturally exposed to this substance, the Panel considers that the consumption of 6′‐SL in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐6SL_02) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. The NF is produced by fermentation with E. coli K‐12 MG1655 INB‐3SL_01, a genetically modified strain of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: 3′‐SL sodium salt, when produced by fermentation with genetically modified strains of E. coli K‐12 DH1, E. coli BL21 (DE3) or E. coli W (ATCC 9637) is already authorised and included in the EU list of NFs. .. The NF is produced by fermentation with E. coli K‐12 MG1655 INB‐3SL_01, which is a genetically modified strain of Genetically Modified:Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. The NF is produced by fermentation with a genetically modified strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. Given that the NF would be consumed to the same extent as the already authorised 3′‐SL sodium salt and taking into account the intrinsic nature of HiMOs with their limited absorption, the absence of toxicologically relevant effects and considering that breastfed infants are naturally exposed to this substance, the Panel considers that the consumption of 3′‐SL in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐3SL_01) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. On the basis of the spectroscopic and chromatographic evidence, the Panel considers that the 3′‐SL present in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐3SL_01) of Article Title: Safety of 6′‐sialyllactose (6′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐6SL_02) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. Given that the NF would be consumed to the same extent as the already authorised 6′‐SL sodium salt and taking into account the intrinsic nature of HMOs with their limited absorption, the absence of toxicologically relevant effects and considering that breastfed infants are naturally exposed to this substance, the Panel considers that the consumption of 6′‐SL in the NF produced by fermentation with a genetically modified strain ( E. coli K‐12 MG1655 INB‐6SL_02) of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: .. The NF is produced by fermentation with E. coli K‐12 MG1655 INB‐3SL_01, a genetically modified strain of Article Title: Safety of 3′‐sialyllactose (3′‐ SL ) sodium salt produced with a derivative strain ( Escherichia coli K‐12 MG1655 INB ‐3SL_01) of E. coli K‐12 MG1655 ( ATCC 700926) as a novel food pursuant to Regulation ( EU ) 2015/2283 Article Snippet: 3′‐SL sodium salt, when produced by fermentation with genetically modified strains of E. coli K‐12 DH1, E. coli BL21 (DE3) or E. coli W (ATCC 9637) is already authorised and included in the EU list of NFs. .. The NF is produced by fermentation with E. coli K‐12 MG1655 INB‐3SL_01, which is a genetically modified strain of |